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Abstract Self-assembling cyclic systems have been of
interest to researchers for over a decade now, and their
wide variety applications have been explored from
electronic devices to medicinal purposes. But still their
discovery for newer innovative applications remains as
valuable as before. In this study, ab initio Hartree–Fock
molecular orbital calculations have been performed on
peptidic and peptidomimetic cyclic compounds to identify
characteristics required in compounds for efficient self-
aggregation. The effect of these characteristics in deter-
mining the pore size and length of nanotube has been
studied. Effect of backbone and substituents on environ-
ment of outer and inner surface and carriage properties has
been studied in detail. Self-aggregating compounds (Ala)12
and (Ala)10 have been predicted to form a tubular structure
with dimensions in nanoscale. They have been predicted to
work as novel drug carriers having inert outer wall and
inner pore. A peptidic self-aggregating compound (Ala)12
has been studied and suggested as carrier for antibiotic
gentamicin to exemplify carriage properties of the designed
compound. Such novel self-aggregatory systems are
expected to help simplify the drug delivery process and
increase bioavailability of various drugs.
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Introduction
Self-aggregating systems offer a variety of potential
applications: from fabricating materials, to optoelectronics,
to formation of nanotubes and drug delivery systems
(Ahn et al. 2002; Jung 1999; Ijima 1991; Harada et al. 1993;
Schnur 1993; Thess et al. 1996; Miyamoto et al. 1996).
Carbon nanotubes are also one such exciting example.
These have been extensively studied experimentally as
well as theoretically (Ahn et al. 2002; Hartgerink et al.
1996; Mintmire et al. 1992; Hamoda et al. 1992; Saito et al.
1992; White et al. 1993). These self-aggregated forms have
also been used for carriage of various types of materials
(Ebbesen and Ajayan 1992; Ajayan and Iijima 1993;
Ajayan et al. 1993; Guerret-Piecourt et al. 1994; Dujardin
et al. 1994; Loiseau and Pascard 1996).
Organic nanotubes have been synthesized by self-aggre-
gation of cyclic peptides (Sloan et al. 1998; Ghadiri et al.
1993, 1994, 1995; Ghadiri 1995; Khazanovich et al. 1994).
Recent studies have highlighted the use of these organic
nanotubes as mimics of biological channels, molecular
adapters for pore-forming proteins, transport vehicles in
drug delivery systems and other nanostructural materials
(Hartgerink et al. 1996; Kim et al. 1998; Fernandez-Lopez
et al. 2001; Amorin et al. 2003; Brea et al. 2006; Sanchez-
Quesada et al. 2000; Clark et al. 1998a, b; Horne et al. 2005;
Ortiz-Acevedo et al. 2005; Schalley 2004; Ashkenasy and
Ghadiri 2004). Recent work by Ghadiri et al. (1993) has
highlighted the spontaneous self-assemblage of cyclic pep-
tides having a flat ring-shaped conformation by controlled
acidification of alkaline peptide solutions. The structures
were made up of even number of alternating D-, L-amino acid
residues. The rings were stacked together through hydrogen-
bonding interactions and formed a hollow tubular cylindrical
structure in the nanoscale and hence called nanotubes.
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Figures 1 and 2 depict some usages of such self-aggre-
gated systems. The interesting aspect is that the dimensions
and properties can be tuned according to needs. Figure 1
describes self-assembling 6–8 residue peptides synthesized
by Ghadiri and colleagues at Scripps Research Institute
(Fernandez-Lopez et al. 2001; Ghadiri et al. 1993, 1994,
1995; Ghadiri 1995; Sanchez-Quesada et al. 2001). These
peptides are capable of forming holes in bacterial mem-
brane disrupting t asstacks lethal to bacteria. Figure 1 also
depicts peptide-polymer hybrid nanotubes synthesized by
Couet et al. (2005). The peptide nanotube in this case is
embedded in a polymer shell. The structure and properties
are determined by both peptide and polymer. The surface-
induced polymerization around nanotube offers shape-
persistent hybrid materials not easily accessed otherwise.
Other research groups have also synthesized self-assem-
bling cyclic peptides and studied their usage in liquid
crystals and drug delivery systems (Tu and Tirrell 2004;
Leclair et al. 2004). Figure 2 shows trapped solvent wire
inside self-assembled cyclic peptide characterized by
Raghavender et al. (2009). These aggregated cyclic pep-
tides form pore across cell membrane which suggests their
bactericidal property. Molecular dynamic simulations by
Dehez and coworkers explain ion transport through these
channels.
In this study, conditions for self-aggregation in cyclic
systems have been explored keeping in mind their pro-
spective usage in aggregated form. The properties of a
cyclic self-aggregated peptide depend upon the backbone
and type of substituents used (Ghadiri et al. 1993, 1994,
1995; Ghadiri 1995; Khazanovich et al. 1994; Kobayashi
et al. 1995). However, changes in stacking behavior with
slight change in backbone and number of residues have not
been clearly understood.
Methods
Ab initio molecular orbital (MO) calculations have been
performed at the Hartree–Fock level utilizing 6-31G basis
set on some large peptidic and peptidomimetic cyclic
compounds to explore and subsequently highlight their
usage for medicinal purposes. Complete geometry opti-
mizations were performed on the monomer and dimer of
the cyclic compounds with a steepest descent approach
utilizing redundant internal coordinates (Peng et al. 1996;
Peng and Schlegel 1994). For convergence the rms of
forces was required to be less than 3 9 10-4. Potential
energy of the system is minimized with respect to all bond
lengths, bond angles and dihedral angles. Stationary points
corresponding to low-energy conformations were obtained
using GAUSSIAN’03 (Frisch et al. 2004) and viewed using
GAUSSVIEW (Dennington et al. 2003).
Self-aggregating tendency of cyclic peptidomimetic
compounds was studied by intermolecular interaction cal-
culations with and without basis set superposition error
(BSSE) estimate. Compounds were stacked over one
another keeping in mind optimum conditions observed for
stacking. Covalent bonding between two compounds was
prohibited. At each step of stacking, stacking efficiency
was evaluated as
Stacking efficiency ¼ Estacked supermolecule  ðEmonomer
 no of monomersÞ
Complete geometry optimization of stacked super-
molecule is not feasible by ab initio calculations.
Stacking efficiency has been computed by single-point
calculation of energy of stacked supermolecule. BSSE
estimate was obtained using Boys Bernardi counterpoise
correction (Boys and Bernardi 1970) method.
After understanding the characteristics required in cyclic
peptide for self-assemblage and assessing feasibility of
existence of self-assembled form, its usage as drug delivery
system was considered. Drugs that cannot be delivered
orally were considered for carriage. A model of solvated
drug being carried was prepared. First the drug was
optimized in gas phase by ab initio calculations. After
completely optimizing drug Gentamicin and self-aggre-
gated carrier that is trimer of (ala)12 in gas phase; the self-
aggregated carrier was filled with water molecules using
Soak option of Impact module (Impact 2010) from Maestro
(Schrodinger 2009). The drug was then manually docked in
soaked carrier displacing water molecules. Resulting model
of solvated Gentamicin carriage by (ala)12 trimer was then
subjected to ab initio molecular orbital geometry optimi-
zation by Berny’s algorithm. This allows water molecules
to properly orient mediating interaction between drug and
carrier.
Conformational reorganization of drug, nanotube and
water molecules was then calculated. Overall stabilization
of the system was evaluated along with reorganization
required in nanotube and its contents. Low reorganization
indicates mutual suitability. Feasibility of usage of self-
aggregated cyclic peptidomimetic system as drug delivery
system was thus predicted.
Results and discussion
We have first studied some peptide and peptidomimetic
systems in their monomeric form to understand change in
characteristics with size and type of backbone and sub-
stituents. Figure 3 depicts optimized conformations for
different monomers with peptide or peptidomimetic back-
bone. All monomers containing peptide backbone and
same number of residues show same inner diameter of
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Fig. 1 Some applications of self-aggregating cyclic peptides
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12.9 A˚. Outer dimensions obviously depend on substituent.
(Ala)12 monomer with CH2NH backbone and CO–O–
backbone shows inner diameters of 10.1 and 10.9 A˚,
respectively. The dependence of pore size on ring size is
obvious. Cyclic peptides with less than six substituents
cannot be used for practical drug carriage purposes. The
type of backbone and the size of backbone thus determine
the diameter of the pore formed by aggregated form of
these cyclic systems. This study concentrates on ring sys-
tems with at least eight substituents so that their practical
usage can be investigated.
Dimerization tendencies of various monomers judged by
intermolecular interaction calculations are shown in
Figs. 4, 5. The interaction energy has been calculated after
complete optimization of dimer. (Ala)12 system with pep-
tide backbone shows good dimerization tendency when
both monomers are in eclipsed orientation as well as when
both the monomers are in staggered orientation (c.f.
Fig. 4). Staggered orientation is preferred due to obvious
alleviation of repulsive interactions between alanine sub-
stituents of one monomer with that of the other. (Val)12
system does not show any dimerization tendency even in
Conduction of hydrated sodium ion
through artificial channel.
Water wire: Conduction of water   
through hydrophobic channel
8,10 and 12 cyclic peptide subunits form tubular structures with
internal pore dimensions in the range of 7-13Å.
They serve as conduit for water.
They can function as size selective ion channel.
They can be used to transport biologically relevant molecules like
glucose across cell membranes.
Fig. 2 Self-aggregating cyclic
peptides as artificial membranes
and channels
518 Appl Nanosci (2013) 3:515–528
123
staggered orientation due to the size of the substituents
which cause repulsion and steric hindrances. (Gln–Ala)6
system also shows appreciable dimerization tendency as
the glutamine residues of monomers can interact by
H-bonding and electrostatic interactions (c.f. Fig. 5). Steric
problem is alleviated due to alternating alanine residues. A
twisted arrangement of monomers is preferred in this case.
Next we have considered dimerization tendency of
monomers containing peptidomimetic backbone. In this
case (Ala)12 system has been studied to avoid any steric
problems. This will enable us understand most suitable
backbone for self-aggregation of such systems. (Ala)12
with CH2NH backbone (c.f. Fig. 6) does not show any
possibility of self-aggregation due to highly hydrophobic
backbone. However, the effect of solvent polarity on self-


































Fig. 3 Effect of backbone on
size of cyclic system
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that solvent molecules may squeeze in between rings of
cyclic peptide but their presence inside pore may lead to
enhanced attractive interactions. This system is ideal for
enhancing levodopa bioavailability in monomeric form as
suggested by us in our previous work (Banerjee and Yadav
2011). (Ala)12 system with (CO–O–) backbone shows only
little tendency to self-aggregate as the backbone contains
enhanced flexibility and tends to pucker in a way not
suitable for efficient self-aggregation. These results are also
depicted in Fig. 6.
Self-aggregation tendency of such systems is thus a
close interplay of substituent type and backbone type. It is
also dependent on overall size of the system (i.e. inner
diameter of cyclic system). However, in this study size
of the system studied is suitable for application under
consideration. Cyclic peptides with less than six amino
acids can practically not be used for carriage of anything
other than a small ion.
(Ala)12 system was chosen to study tubular formation by
self-aggregation. (Ala)12 system should give rise to tubular
structure that is largely hydrophobic and inert from inside
(Jishi et al. 1998) as well as from outside. Such an
aggregated system may be used as drug delivery system to
deliver contents inside cell at target.
Self-aggregation in (ala)12 system was studied by
gradually increasing number of monomers and evaluating
interaction energy until enhanced tendency for aggregation
was being observed (i.e. until interaction energy was
increasingly negative). As the aggregated system becomes
larger, artifacts due to methodology tend to creep in.
Interaction energy= -75.58 kCal/ mol





Interaction energy= -84.50 kCal/ mol














Interaction energy= + 133.54 kCal/mol
Fig. 4 Effect of hydrophobic
substituents on dimerization
tendency of cyclic peptides
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Therefore, stacking efficiency has been studied at larger
basis set as well; evaluating basis set superimposition error
(BSSE) simultaneously each time until computational
facilities at hand could support ab initio HF calculations.1
Results for the same are collected in Table 1. Some of the
results are depicted in Fig. 7. An efficient aggregation of
14 monomer units was observed after which interaction
starts to decrease. Therefore, a small hydrophobic sub-
stituent in a cyclic peptide allows nanotube formation of
diameter *13 A˚ and length 71–75 A˚. This length is suf-
ficient enough to allow usage of these systems as drug
delivery systems. The optimum distance between two
stacked rings is between 2.6 and 3.1 A˚. This is the nearest
Staggered orientation
Interaction energy= -76.61 kCal/mol
Dimer of cyclic (Gln-Ala)6 system 
with (-CO-NH-) linkage
Interaction energy= -82.39kCal/mol
Dimer of cyclic (Glu-Ala-Gln-Ala)3






Fig. 5 Effect of polar substituents on dimerization tendency of cyclic peptides
1 When memory requirement crosses 2GB, it is not possible to
compute using 32 bit machine.
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distance between carbonyl of one backbone and –NH– of
the adjoining monomer backbone.
The length to width ratio of tubular structure formed
could be an important parameter in judging the strength
and stability of nanotube formed similar to aspect ratio for
fibers. To investigate length to width ratio for different
systems for comparison we have studied (ala)10 system
also. Results for (ala)10 are shown in Fig. 8. For (ala)12
length to diameter ratio predicted is 4 as compared with a
value of 3 for (ala)10 system. Extrapolation of these results
predicts a value of 1 for (ala)6. (Glu–ala–gln–ala)n system
has been extensively prepared and studied by Ghadiri et al.
Self-aggregation has been observed only when n = 2–4
(Miyamoto et al. 1996).
If cyclic system is too small, efficient aggregation can-
not be observed due to strain in backbone and if it is too
Interaction energy= -76.69kCal/mol
Dimer of cyclic (Glu-Ala-Gln-Ala)3 
system with (-CO-NH-) linkage     
Staggered orientation
Side view Top view
Top viewSide view
Repulsive Interaction
Dimer of cyclic (Ala)12 system 
with (-CH2-NH-) linkage
Twisted orientation
No dimerization tendency 





Interaction energy= -24.49 kCal/mol
Dimer of cyclic (Ala)12 system 
with (-CO-O-) linkage
Fig. 6 Effect of backbone on dimerization tendency of cyclic peptides
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large flexibility introduced in backbone does not allow
efficient self-aggregation. These results are in agreement
with our theoretical predictions.
Some natural peptides of diverse microbial origin pos-
sess the ability to self-aggregate at lipid phase and form
trans membrane channels across lipid bilayers. Such pep-
tides have interesting potential to be used as artificial
membranes. However, the design and synthesis of artificial
system is not an easy task. Considering work in progress by
several groups along these lines, we have explored the
usage of self-aggregated cyclic peptides as drug delivery
systems. Drugs with intracellular targets show poor bio-
availability. Some may lead to toxic effects when taken
orally. In such cases a drug delivery system may be used to
reduce toxicity and enhance therapeutic index. Carriage of
antibiotic gentamicin encapsulated in peptide tubular
structure has been considered in this study. Gentamicin is
an aminoglycosidic antibiotic used to protect us against a
wide spectrum of bacteria gram positive as well as gram
negative (Kadurugamuwa and Beveridge 1998). Its use is
restricted to low doses due to accumulation of its residues
in kidney (Cabanes et al. 1998). Delivery of gentamicin at
target may reduce its harmful effects.
Chemical structure for gentamicin and its completely
optimized conformation are shown in Fig. 9. A minimum
length drug delivery system formed by (ala)12 cyclic
peptide was taken to encapsulate gentamicin. Desired
amount of self-aggregation may be achieved by pH control
(Rajagopal et al. 2009; Aggeli et al. 2003). Complex was
then subjected to complete geometry optimization to
understand reorganization in delivery system required to
efficiently carry gentamicin and to understand whether
interaction is strong enough to hold gentamicin until
delivery at target. These results are also shown in Fig. 9.
Reorganizations required in carrier as well as drug are both
small (carrier reorganization = 1.07 kCal/mol, drug reor-
ganization = 0.46 kCal/mol) facilitating unhindered car-
riage of drug. Overall interaction energy is also reasonable
to hold it until delivery at target such that premature
expulsion of drug will be avoided. Release of drug at target
may be natural by passive diffusion or by enzymatic dis-
integration of peptide carrier.
Table 1 Self-assemblage tendency in (Ala)12 and (Ala)10 systems
Number of monomer
units stacked
(Ala)12 system (Ala)10 system























4 -47.19 -37.58 9.61 -140.08 -106.13 33.95 -42.46
5 -57.19 -42.23 14.96 -176.00 -138.76 37.24 -56.06
6 -54.03 -35.93 18.10 -229.63 – – -69.34
7 -88.36 – – -278.44 – – -83.44
8 -107.57 – – -333.30 – – -97.14
9 -114.48 – – – – – -134.37
10 -129.09 – – – – – -125.76
11 -158.23 – – – – – -139.87
12 -162.74 – – – – – -170.16
13 -176.40 – – – – – -167.55
14 -236.00 – – – – – -175.86
15 -183.10 – – – – – -182.30
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Further, to simulate more realistically we have taken
drug in solvated form. Again carrier and solvated drug
complex have been completely optimized. Water mole-
cules also orient to give maximum stabilization to
complex. Results for the same are depicted in Fig. 10. For
solvated drug carriage also results indicate low reorgani-
zation and appropriate carriage efficiency.
9 monomer units stacked
Interaction energy= -114.48 kCal/mol
11 monomer units stacked
Interaction energy= -158.23 kCal/mol
3 monomer units stacked
Int. energy= -28.81 kCal/mol
5 monomer units stacked
Int. energy= -57.19 kCal/mol
7 monomer units stacked
Interaction energy= -88.36 kCal/mol
13 monomer units stacked
Interaction energy= -176.40 kCal/mol
14 monomer units stacked
Interaction energy= -236.00 kCal/mol
Fig. 7 Self-aggregation in (Ala)12 system
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Concluding remarks
Overall study indicates that self-assembled cyclic peptides
can be used in drug delivery systems to enhance bio-
availability of certain drugs acting intracellularly.
Following inferences are drawn from this study:
1. In self-aggregating cyclic systems the type of back-
bone and size of backbone determines the diameter of
pore formed.
2. Flat cyclic systems with small substituents favoring
intermolecular H-bonding show appreciable self-
assemblage tendency.
8 monomer units stacked
Interaction energy= -97.14 kCal/mol
9 monomer units stacked
Interaction energy = -134.37 kCal/mol
5 monomer units stacked
Interaction energy= -56.06 kCal/mol
6 monomer units stacked
Interaction energy= -69.34 kCal/mol
3 monomer units stacked
Interaction energy= -27.28 kCal/mol
4 monomer units stacked
Interaction energy= -42.46 kCal/mol
Fig. 8 Self-aggregation in (Ala)10 system
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3. Highly hydrophobic backbone does not allow self-
aggregation when studied in gas phase. Further work
needs to be done to study stabilities in actual solvent
environment.
4. Small hydrophobic substituent in a cyclic peptide
allows nanotube formation of diameter *13 A˚ and
length 71–75 A˚. The optimum distance between two
stacked rings is between 2.6 and 3.1 A˚.
5. Trimer of cyclic peptide (ala)12 has been suggested as
a carrier for solvated antibiotic gentamicin to avoid its
side effects and enhance bioavailability at target and


















Electrostatic gain= -8.72 kCal/mol
(Carrier +Drug)reorganization= 1.53 kCal/mol
Overall stabilization= -7.19 kCal/mol
Top  veiw Side veiw





Interaction energy= -136.82 kCal/mol
Trimer of cyclic (Ala)12 system 
with  (-CO-NH-) linkage




Fig. 9 a Chemical structure of gentamicin, b optimized gentamicin, c empty carrier. d complex, and e reorganized carrier
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